Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report

Acute myeloid leukemia (AML) with FUS‐ERG has a poor prognosis regardless of allo‐hematopoietic stem cell transplantation (HSCT). Maintenance therapy such as azacitidine after allo‐HSCT for AML with FUS‐ERG may be clinically meaningful.

Detalles Bibliográficos
Autores principales: Keino, Dai, Mori, Takashi, Morimoto, Mizuho, Kondo, Kensuke, Mori, Tetsuya, Kinoshita, Akitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878075/
https://www.ncbi.nlm.nih.gov/pubmed/31788268
http://dx.doi.org/10.1002/ccr3.2461
_version_ 1783473464258068480
author Keino, Dai
Mori, Takashi
Morimoto, Mizuho
Kondo, Kensuke
Mori, Tetsuya
Kinoshita, Akitoshi
author_facet Keino, Dai
Mori, Takashi
Morimoto, Mizuho
Kondo, Kensuke
Mori, Tetsuya
Kinoshita, Akitoshi
author_sort Keino, Dai
collection PubMed
description Acute myeloid leukemia (AML) with FUS‐ERG has a poor prognosis regardless of allo‐hematopoietic stem cell transplantation (HSCT). Maintenance therapy such as azacitidine after allo‐HSCT for AML with FUS‐ERG may be clinically meaningful.
format Online
Article
Text
id pubmed-6878075
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68780752019-11-29 Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report Keino, Dai Mori, Takashi Morimoto, Mizuho Kondo, Kensuke Mori, Tetsuya Kinoshita, Akitoshi Clin Case Rep Case Reports Acute myeloid leukemia (AML) with FUS‐ERG has a poor prognosis regardless of allo‐hematopoietic stem cell transplantation (HSCT). Maintenance therapy such as azacitidine after allo‐HSCT for AML with FUS‐ERG may be clinically meaningful. John Wiley and Sons Inc. 2019-09-27 /pmc/articles/PMC6878075/ /pubmed/31788268 http://dx.doi.org/10.1002/ccr3.2461 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Keino, Dai
Mori, Takashi
Morimoto, Mizuho
Kondo, Kensuke
Mori, Tetsuya
Kinoshita, Akitoshi
Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report
title Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report
title_full Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report
title_fullStr Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report
title_full_unstemmed Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report
title_short Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood stem cell transplantation: A case report
title_sort salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/fus‐erg and early relapse after allogeneic blood stem cell transplantation: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878075/
https://www.ncbi.nlm.nih.gov/pubmed/31788268
http://dx.doi.org/10.1002/ccr3.2461
work_keys_str_mv AT keinodai salvagetherapywithazacitidineforpediatricacutemyeloidleukemiawitht1621p11q22fusergandearlyrelapseafterallogeneicbloodstemcelltransplantationacasereport
AT moritakashi salvagetherapywithazacitidineforpediatricacutemyeloidleukemiawitht1621p11q22fusergandearlyrelapseafterallogeneicbloodstemcelltransplantationacasereport
AT morimotomizuho salvagetherapywithazacitidineforpediatricacutemyeloidleukemiawitht1621p11q22fusergandearlyrelapseafterallogeneicbloodstemcelltransplantationacasereport
AT kondokensuke salvagetherapywithazacitidineforpediatricacutemyeloidleukemiawitht1621p11q22fusergandearlyrelapseafterallogeneicbloodstemcelltransplantationacasereport
AT moritetsuya salvagetherapywithazacitidineforpediatricacutemyeloidleukemiawitht1621p11q22fusergandearlyrelapseafterallogeneicbloodstemcelltransplantationacasereport
AT kinoshitaakitoshi salvagetherapywithazacitidineforpediatricacutemyeloidleukemiawitht1621p11q22fusergandearlyrelapseafterallogeneicbloodstemcelltransplantationacasereport

Ejemplares similares